secukinumab
novartis
['secukinumab', ' psa']
benesova et al. higher treatment response to secukinumab in both male and female as patients when diagnosed earlier. no such effect seen in psa patients. emphasises need to reduce diagnostic delay in as. #acr22 abstr#1497 
Rheumatologist @stjamesdublin , Associate Professor @tcddublin , Acute Medicine, Vasculitis, ILD, Retired @Emeunet Executive Committee member, @rheum_covid CASC